Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises IK Partners in the divestment of Carspect to TÜV SÜD
Mandate

Vinge advises IK Partners in the divestment of Carspect to TÜV SÜD

August 19, 2024 Banking and Finance M&A Financial Regulatory Real Estate and Construction Employment and Benefits Intellectual Property Commercial Agreements Automotive, Mobility and Electrification

Vinge has advised IK Partners and the other owners in connection with the divestment of Carspect Group Holding AB to TÜV SÜD Aktiengesellschaft. Carspect is a leading provider of vehicle inspections in Sweden, Estonia and Latvia, with a total of approximately 150 stations and over 500 employees.

Vinge's team consisted primarily of Jonas Bergström, Johanna Wiberg, Vilhelm Rondahl and Ida Appelgren (M&A), Lionardo Ojeda, Rebecka Margolin, Sofia Haggren and Nour Makie (Banking and Finance), ohan Cederblad (Permits & Accreditation), Kristoffer Larsson (Real Estate & Environment), Ebba Svenburg and Emil Lindwall (Employment Law), Martin Boström (Commercial Contracts / IT), Felizia Wiker (IP) and Anna Ekdahl Roos, Ellinore Boström Andersson and Gabriella Balbo (Transaction Support).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026